{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:33:24Z","timestamp":1793093604089,"version":"4.5.0"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Inflamm"],"DOI":"10.1186\/s12950-025-00438-w","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T17:05:50Z","timestamp":1747069550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Biological mechanisms and therapeutic prospects of interleukin-33 in pathogenesis and treatment of allergic disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Mohammad Chand","family":"Jamali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma\u2019a H.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azfar","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Azhar","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Al Abdulmonem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar Abdullah","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Mansuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzail","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Mudhafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Shafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroonrashid M.","family":"Hattiwale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"438_CR1","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/all.12470","volume":"69","author":"T Zuberbier","year":"2014","unstructured":"Zuberbier T, L\u00f6tvall J, Simoens S, Subramanian S, Church MK. Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review. Allergy. 2014;69:1275\u20139.","journal-title":"Allergy"},{"key":"438_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/all.13373","volume":"73","author":"K Samitas","year":"2018","unstructured":"Samitas K, Carter A, Kariyawasam H, Xanthou G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2018;73:993\u20131002.","journal-title":"Allergy"},{"key":"438_CR3","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1111\/all.13496","volume":"73","author":"A Yii","year":"2018","unstructured":"Yii A, Tay TR, Choo X, Koh M, Tee A, Wang DY. Precision medicine in united airways disease: a treatable traits approach. Allergy. 2018;73:1964\u201378.","journal-title":"Allergy"},{"key":"438_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/all.13315","volume":"73","author":"K Agrawal","year":"2018","unstructured":"Agrawal K, Arora N. Serine protease allergen favours Th2 responses via PAR-2 and STAT 3 activation in murine model. Allergy. 2018;73:569\u201375.","journal-title":"Allergy"},{"key":"438_CR5","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/all.14068","volume":"74","author":"J Bousquet","year":"2019","unstructured":"Bousquet J, Akdis CA, Grattan C, Eigenmann PA, Hoffmann-Sommergruber K, Agache I, Jutel M. Highlights and recent developments in airway diseases in EAACI journals (2018). Allergy. 2019;74:2329\u201341.","journal-title":"Allergy"},{"key":"438_CR6","doi-asserted-by":"publisher","first-page":"eaat1604","DOI":"10.1126\/sciimmunol.aat1604","volume":"3","author":"CM Lloyd","year":"2018","unstructured":"Lloyd CM, Snelgrove RJ. Type 2 immunity: expanding our view. Sci Immunol. 2018;3:eaat1604.","journal-title":"Sci Immunol"},{"key":"438_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri2735","volume":"10","author":"WE Paul","year":"2010","unstructured":"Paul WE, Zhu J. How are TH2-type immune responses initiated and amplified? Nat Rev Immunol. 2010;10:225\u201335.","journal-title":"Nat Rev Immunol"},{"key":"438_CR8","doi-asserted-by":"crossref","unstructured":"Crespo JF, Cabanillas B. (2023) Recent advances in cellular and molecular mechanisms of IgE-mediated food allergy. Food Chemistry: 135500.","DOI":"10.1016\/j.foodchem.2023.135500"},{"key":"438_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jaci.2018.07.037","volume":"143","author":"C Persson","year":"2019","unstructured":"Persson C. Airways exudation of plasma macromolecules: innate defense, epithelial regeneration, and asthma. J Allergy Clin Immunol. 2019;143:1271\u201386.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR10","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1111\/all.15089","volume":"76","author":"I Ogulur","year":"2021","unstructured":"Ogulur I, Pat Y, Ardicli O, Barletta E, Cevhertas L, Fernandez-Santamaria R, Huang M, Bel Imam M, Koch J, Ma S. Advances and highlights in biomarkers of allergic diseases. Allergy. 2021;76:3659\u201386.","journal-title":"Allergy"},{"key":"438_CR11","doi-asserted-by":"crossref","unstructured":"Girkin JL, Maltby S, Bartlett NW. (2022) Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell. Eur Respiratory Rev 31.","DOI":"10.1183\/16000617.0274-2021"},{"key":"438_CR12","doi-asserted-by":"publisher","first-page":"749077","DOI":"10.3389\/fphys.2021.749077","volume":"12","author":"SL Johnston","year":"2021","unstructured":"Johnston SL, Goldblatt DL, Evans SE, Tuvim MJ, Dickey BF. Airway epithelial innate immunity. Front Physiol. 2021;12:749077.","journal-title":"Front Physiol"},{"key":"438_CR13","doi-asserted-by":"crossref","unstructured":"Patel NN, Kohanski MA, Maina IW, Workman AD, Herbert DBR, Cohen NA. Sentinels at the wall: epithelial-derived cytokines serve as triggers of upper airway type 2 inflammationInternational. forum of allergy & rhinology Wiley Online Library; 2019. pp. 93\u20139.","DOI":"10.1002\/alr.22206"},{"key":"438_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12032-023-02051-4","volume":"40","author":"SHA Eivary","year":"2023","unstructured":"Eivary SHA, Kheder RK, Najmaldin SK, Kheradmand N, Esmaeili S-A, Hajavi J. Implications of IL-21 in solid tumor therapy. Med Oncol. 2023;40:191.","journal-title":"Med Oncol"},{"key":"438_CR15","doi-asserted-by":"publisher","first-page":"2004433","DOI":"10.1002\/advs.202004433","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: from clinical significance to quantification. Adv Sci. 2021;8:2004433.","journal-title":"Adv Sci"},{"key":"438_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000488015","volume":"176","author":"PD Mitchell","year":"2018","unstructured":"Mitchell PD, Salter BM, Oliveria JP, El-Gammal A, Tworek D, Smith SG, Sehmi R, Gauvreau GM, O\u2019Byrne PM. IL-33 and its receptor ST2 after inhaled allergen challenge in allergic asthmatics. Int Arch Allergy Immunol. 2018;176:133\u201342.","journal-title":"Int Arch Allergy Immunol"},{"key":"438_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.164.2.2008120","volume":"164","author":"K Oshikawa","year":"2001","unstructured":"Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, Tominaga S-i, Sugiyama Y. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med. 2001;164:277\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"438_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","volume":"163","author":"ES Baekkevold","year":"2003","unstructured":"Baekkevold ES, Roussign\u00e9 M, Yamanaka T, Johansen F-E, Jahnsen FL, Amalric F, Brandtzaeg P, Erard M, Haraldsen G, Girard J-P. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol. 2003;163:69\u201379.","journal-title":"Am J Pathol"},{"key":"438_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol C, Girard JP. Interleukin-33 (IL\u201033): a nuclear cytokine from the IL\u20101 family. Immunol Rev. 2018;281:154\u201368.","journal-title":"Immunol Rev"},{"key":"438_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbrc.2012.08.047","volume":"426","author":"L Bianchetti","year":"2012","unstructured":"Bianchetti L, Marini MA, Isgr\u00f2 M, Bellini A, Schmidt M, Mattoli S. IL-33 promotes the migration and proliferation of circulating fibrocytes from patients with allergen-exacerbated asthma. Biochem Biophys Res Commun. 2012;426:116\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"438_CR21","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.4049\/jimmunol.1003080","volume":"187","author":"S Ali","year":"2011","unstructured":"Ali S, Mohs A, Thomas M, Klare J, Ross R, Schmitz ML, Martin MU. The dual function cytokine IL-33 interacts with the transcription factor NF-\u03baB to dampen NF-\u03baB\u2013stimulated gene transcription. J Immunol. 2011;187:1609\u201316.","journal-title":"J Immunol"},{"key":"438_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bbrc.2012.04.005","volume":"421","author":"Y-S Choi","year":"2012","unstructured":"Choi Y-S, Park JA, Kim J, Rho S-S, Park H, Kim Y-M, Kwon Y-G. Nuclear IL-33 is a transcriptional regulator of NF-\u03baB p65 and induces endothelial cell activation. Biochem Biophys Res Commun. 2012;421:305\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"438_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard J-P, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16:676\u201389.","journal-title":"Nat Rev Immunol"},{"key":"438_CR24","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1002\/ehf2.14111","volume":"9","author":"E Mehrabi Nasab","year":"2022","unstructured":"Mehrabi Nasab E, Hassanzadeh Makoei R, Aghajani H, Athari SS. IL-33\/ST2 pathway as upper\u2010hand of inflammation in allergic asthma contributes as predictive biomarker in heart failure. ESC Heart Fail. 2022;9:3785\u201390.","journal-title":"ESC Heart Fail"},{"key":"438_CR25","doi-asserted-by":"publisher","first-page":"13242","DOI":"10.3390\/ijms232113242","volume":"23","author":"M Trimarchi","year":"2022","unstructured":"Trimarchi M, Lauritano D, Ronconi G, Caraffa A, Gallenga CE, Frydas I, Kritas SK, Calvisi V, Conti P. Mast cell cytokines in Acute and Chronic Gingival tissue inflammation: role of IL-33 and IL-37. Int J Mol Sci. 2022;23:13242.","journal-title":"Int J Mol Sci"},{"key":"438_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev-immunol-101320-124243","volume":"40","author":"GK Dwyer","year":"2022","unstructured":"Dwyer GK, D\u2019Cruz LM, Turnquist HR. Emerging functions of IL-33 in homeostasis and immunity. Annu Rev Immunol. 2022;40:15\u201343.","journal-title":"Annu Rev Immunol"},{"key":"438_CR27","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3389\/fimmu.2019.01412","volume":"10","author":"JK Fields","year":"2019","unstructured":"Fields JK, G\u00fcnther S, Sundberg EJ. Structural basis of IL-1 family cytokine signaling. Front Immunol. 2019;10:1412.","journal-title":"Front Immunol"},{"key":"438_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cell.2020.05.050","volume":"182","author":"PT Nguyen","year":"2020","unstructured":"Nguyen PT, Dorman LC, Pan S, Vainchtein ID, Han RT, Nakao-Inoue H, Taloma SE, Barron JJ, Molofsky AB, Kheirbek MA. Microglial remodeling of the extracellular matrix promotes synapse plasticity. Cell. 2020;182:388\u2013403. e315.","journal-title":"Cell"},{"key":"438_CR29","doi-asserted-by":"publisher","first-page":"34255","DOI":"10.1038\/srep34255","volume":"6","author":"V Gautier","year":"2016","unstructured":"Gautier V, Cayrol C, Farache D, Roga S, Monsarrat B, Burlet-Schiltz O, Gonzalez de Peredo A, Girard J-P. Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cells. Sci Rep. 2016;6:34255.","journal-title":"Sci Rep"},{"key":"438_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1398-9995.2010.02445.x","volume":"66","author":"C Thijs","year":"2011","unstructured":"Thijs C, M\u00fcller A, Rist L, Kummeling I, Snijders B, Huber M, Van Ree R, Sim\u00f5es-W\u00fcst A, Dagnelie P, Van Den Brandt P. Fatty acids in breast milk and development of atopic eczema and allergic sensitisation in infancy. Allergy. 2011;66:58\u201367.","journal-title":"Allergy"},{"key":"438_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong T, Liu L, Jiang W, Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020;20:95\u2013112.","journal-title":"Nat Rev Immunol"},{"key":"438_CR32","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.clinthera.2016.02.028","volume":"38","author":"F Pandolfi","year":"2016","unstructured":"Pandolfi F, Altamura S, Frosali S, Conti P. Key role of DAMP in inflammation, cancer, and tissue repair. Clin Ther. 2016;38:1017\u201328.","journal-title":"Clin Ther"},{"key":"438_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cytogfr.2015.07.017","volume":"26","author":"M De la Fuente","year":"2015","unstructured":"De la Fuente M, MacDonald TT, Hermoso MA. The IL-33\/ST2 axis: role in health and disease. Cytokine Growth Factor Rev. 2015;26:615\u201323.","journal-title":"Cytokine Growth Factor Rev"},{"key":"438_CR34","doi-asserted-by":"crossref","unstructured":"Di Salvo E, Ventura-Spagnolo E, Casciaro M, Navarra M, Gangemi S. (2018) IL-33\/IL-31 axis: a potential inflammatory pathway. Mediators of inflammation 2018.","DOI":"10.1155\/2018\/3858032"},{"key":"438_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","volume":"31","author":"C Cayrol","year":"2014","unstructured":"Cayrol C, Girard J-P. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 2014;31:31\u20137.","journal-title":"Curr Opin Immunol"},{"key":"438_CR36","doi-asserted-by":"crossref","unstructured":"Martin MU. (2013) Special aspects of interleukin-33 and the IL-33 receptor complexSeminars in immunology Elsevier, pp. 449\u2013457.","DOI":"10.1016\/j.smim.2013.10.006"},{"key":"438_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.it.2013.11.003","volume":"35","author":"Y Endo","year":"2014","unstructured":"Endo Y, Hirahara K, Yagi R, Tumes DJ, Nakayama T. Pathogenic memory type Th2 cells in allergic inflammation. Trends Immunol. 2014;35:69\u201378.","journal-title":"Trends Immunol"},{"key":"438_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/all.13295","volume":"73","author":"T Iinuma","year":"2018","unstructured":"Iinuma T, Okamoto Y, Morimoto Y, Arai T, Sakurai T, Yonekura S, Sakurai D, Hirahara K, Nakayama T. Pathogenicity of memory Th2 cells is linked to stage of allergic rhinitis. Allergy. 2018;73:479\u201389.","journal-title":"Allergy"},{"key":"438_CR39","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1038\/s41467-021-26347-z","volume":"12","author":"I Aneas","year":"2021","unstructured":"Aneas I, Decker DC, Howard CL, Sobreira DR, Sakabe NJ, Blaine KM, Stein MM, Hrusch CL, Montefiori LE, Tena J. Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region. Nat Commun. 2021;12:6115.","journal-title":"Nat Commun"},{"key":"438_CR40","doi-asserted-by":"publisher","first-page":"e62144","DOI":"10.1371\/journal.pone.0062144","volume":"8","author":"A Latiano","year":"2013","unstructured":"Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro TT, Bossa F, Merla G, Augello B, Latiano T, Corritore G. Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease. PLoS ONE. 2013;8:e62144.","journal-title":"PLoS ONE"},{"key":"438_CR41","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.4049\/jimmunol.181.9.5981","volume":"181","author":"M Suzukawa","year":"2008","unstructured":"Suzukawa M, Iikura M, Koketsu R, Nagase H, Tamura C, Komiya A, Nakae S, Matsushima K, Ohta K, Yamamoto K. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol. 2008;181:5981\u20139.","journal-title":"J Immunol"},{"key":"438_CR42","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/sji.12284","volume":"81","author":"S Zeng","year":"2015","unstructured":"Zeng S, Wu J, Liu J, Qi F, Liu B. IL-33 receptor (ST2) signalling is important for regulation of Th2\u2010mediated airway inflammation in a murine model of acute respiratory syncytial virus infection. Scand J Immunol. 2015;81:494\u2013501.","journal-title":"Scand J Immunol"},{"key":"438_CR43","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s12079-018-0464-4","volume":"12","author":"SM Pinto","year":"2018","unstructured":"Pinto SM, Subbannayya Y, Rex D, Raju R, Chatterjee O, Advani J, Radhakrishnan A, Keshava Prasad T, Wani MR, Pandey A. A network map of IL-33 signaling pathway. J cell Communication Signal. 2018;12:615\u201324.","journal-title":"J cell Communication Signal"},{"key":"438_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/01902148.2013.870261","volume":"40","author":"HY Lee","year":"2014","unstructured":"Lee HY, Rhee CK, Kang JY, Byun JH, Choi JY, Kim SJ, Kim YK, Kwon SS, Lee SY. Blockade of IL-33\/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp Lung Res. 2014;40:66\u201376.","journal-title":"Exp Lung Res"},{"key":"438_CR45","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.coi.2010.10.006","volume":"22","author":"CM Lloyd","year":"2010","unstructured":"Lloyd CM. IL-33 family members and asthma\u2013bridging innate and adaptive immune responses. Curr Opin Immunol. 2010;22:800\u20136.","journal-title":"Curr Opin Immunol"},{"key":"438_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cellimm.2011.05.008","volume":"270","author":"LPA Dourado","year":"2011","unstructured":"Dourado LPA, Noviello MLM, Alvarenga DM, Menezes Z, Perez DA, Batista NV, Menezes GB, Ferreira AVM, de Souza DG, Cara DC. Experimental food allergy leads to adipose tissue inflammation, systemic metabolic alterations and weight loss in mice. Cell Immunol. 2011;270:198\u2013206.","journal-title":"Cell Immunol"},{"key":"438_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/oby.20246","volume":"21","author":"GR Lee","year":"2013","unstructured":"Lee GR, Shin MK, Yoon DJ, Kim AR, Yu R, Park NH, Han IS. Topical application of capsaicin reduces visceral adipose fat by affecting adipokine levels in high-fat diet\u2010induced obese mice. Obesity. 2013;21:115\u201322.","journal-title":"Obesity"},{"key":"438_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jdermsci.2016.10.008","volume":"85","author":"T Oshio","year":"2017","unstructured":"Oshio T, Komine M, Tsuda H, Tominaga S-i, Saito H, Nakae S, Ohtsuki M. Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice. J Dermatol Sci. 2017;85:106\u201314.","journal-title":"J Dermatol Sci"},{"key":"438_CR49","doi-asserted-by":"publisher","first-page":"e0161507","DOI":"10.1371\/journal.pone.0161507","volume":"11","author":"J Siede","year":"2016","unstructured":"Siede J, Fr\u00f6hlich A, Datsi A, Hegazy AN, Varga DV, Holecska V, Saito H, Nakae S, L\u00f6hning M. IL-33 receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 T cell proliferation through IL-10 and TGF\u03b2 release. PLoS ONE. 2016;11:e0161507.","journal-title":"PLoS ONE"},{"key":"438_CR50","doi-asserted-by":"publisher","first-page":"15502","DOI":"10.1073\/pnas.1410700111","volume":"111","author":"E Lefran\u00e7ais","year":"2014","unstructured":"Lefran\u00e7ais E, Duval A, Mirey E, Roga S, Espinosa E, Cayrol C, Girard J-P. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc Natl Acad Sci. 2014;111:15502\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"438_CR51","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1128\/IAI.02908-14","volume":"83","author":"O Rostan","year":"2015","unstructured":"Rostan O, Arshad MI, Piquet-Pellorce C, Robert-Gangneux F, Gangneux J-P, Samson M. Crucial and diverse role of the interleukin-33\/ST2 axis in infectious diseases. Infect Immun. 2015;83:1738\u201348.","journal-title":"Infect Immun"},{"key":"438_CR52","doi-asserted-by":"publisher","first-page":"e0123163","DOI":"10.1371\/journal.pone.0123163","volume":"10","author":"MB Soyka","year":"2015","unstructured":"Soyka MB, Holzmann D, Basinski TM, Wawrzyniak M, Bannert C, B\u00fcrgler S, Akkoc T, Treis A, R\u00fcckert B, Akdis M. The induction of IL-33 in the sinus epithelium and its influence on T-helper cell responses. PLoS ONE. 2015;10:e0123163.","journal-title":"PLoS ONE"},{"key":"438_CR53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5213\/inj.2015.19.3.142","volume":"19","author":"TY Jang","year":"2015","unstructured":"Jang TY, Kim YH. Interleukin-33 and mast cells bridge innate and adaptive immunity: from the allergologist\u2019s perspective. Int Neurourol J. 2015;19:142.","journal-title":"Int Neurourol J"},{"key":"438_CR54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/ni.3370","volume":"17","author":"NT Martin","year":"2016","unstructured":"Martin NT, Martin MU. Interleukin 33 is a guardian of barriers and a local alarmin. Nat Immunol. 2016;17:122\u201331.","journal-title":"Nat Immunol"},{"key":"438_CR55","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.3390\/cells11203237","volume":"11","author":"H Guo","year":"2022","unstructured":"Guo H, Bossila EA, Ma X, Zhao C, Zhao Y. Dual immune regulatory roles of interleukin-33 in pathological conditions. Cells. 2022;11:3237.","journal-title":"Cells"},{"key":"438_CR56","doi-asserted-by":"crossref","unstructured":"Miller JE, Lingegowda H, Symons LK, Bougie O, Young SL, Lessey BA, Koti M, Tayade C. IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis. JCI insight 6. 2021.","DOI":"10.1172\/jci.insight.149699"},{"key":"438_CR57","doi-asserted-by":"crossref","unstructured":"Velayutham M, Roessing AS, Shiva S, Turnquist HR. IL-33 induces a metabolic programming supporting dendritic cells tolerogenicity. J Immunol 202: 2019;125.112-125.112.","DOI":"10.4049\/jimmunol.202.Supp.125.12"},{"key":"438_CR58","first-page":"530","volume":"121","author":"M Enoksson","year":"2013","unstructured":"Enoksson M, M\u00f6ller-Westerberg C, Wicher G, Fallon PG, Forsberg-Nilsson K, Lunderius-Andersson C, Nilsson G. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell\u2013dependent. Blood J Am Soc Hematol. 2013;121:530\u20136.","journal-title":"Blood J Am Soc Hematol"},{"key":"438_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/imr.12552","volume":"278","author":"LY Drake","year":"2017","unstructured":"Drake LY, Kita H. IL-33: biological properties, functions, and roles in airway disease. Immunol Rev. 2017;278:173\u201384.","journal-title":"Immunol Rev"},{"key":"438_CR60","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","volume":"123","author":"MA Rank","year":"2009","unstructured":"Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H. IL-33\u2013activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol. 2009;123:1047\u201354.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR61","doi-asserted-by":"crossref","unstructured":"Pastorelli L, Garg RR, Hoang SB, Spina L, Mattioli B, Scarpa M, Fiocchi C, Vecchi M, Pizarro TT. (2010) Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1\/Th2 driven enteritis. Proceedings of the National Academy of Sciences 107: 8017\u20138022.","DOI":"10.1073\/pnas.0912678107"},{"key":"438_CR62","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3389\/fimmu.2019.00522","volume":"10","author":"F Alvarez","year":"2019","unstructured":"Alvarez F, Fritz JH, Piccirillo CA. Pleiotropic effects of IL-33 on CD4\u2009+\u2009T cell differentiation and effector functions. Front Immunol. 2019;10:522.","journal-title":"Front Immunol"},{"key":"438_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imlet.2015.01.008","volume":"164","author":"J Lu","year":"2015","unstructured":"Lu J, Kang J, Zhang C, Zhang X. The role of IL-33\/ST2L signals in the immune cells. Immunol Lett. 2015;164:11\u20137.","journal-title":"Immunol Lett"},{"key":"438_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/intimm\/dxr006","volume":"23","author":"J Louten","year":"2011","unstructured":"Louten J, Rankin AL, Li Y, Murphy EE, Beaumont M, Moon C, Bourne P, McClanahan TK, Pflanz S, de Waal Malefyt R. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. Int Immunol. 2011;23:307\u201315.","journal-title":"Int Immunol"},{"key":"438_CR65","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","volume":"42","author":"AB Molofsky","year":"2015","unstructured":"Molofsky AB, Savage AK, Locksley RM. Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity. 2015;42:1005\u201319.","journal-title":"Immunity"},{"key":"438_CR66","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.it.2016.03.007","volume":"37","author":"M Peine","year":"2016","unstructured":"Peine M, Marek RM, L\u00f6hning M. IL-33 in T cell differentiation, function, and immune homeostasis. Trends Immunol. 2016;37:321\u201333.","journal-title":"Trends Immunol"},{"key":"438_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/08820139.2020.1804399","volume":"51","author":"S Falahi","year":"2022","unstructured":"Falahi S, Mortazavi SHR, Salari F, Koohyanizadeh F, Rezaeimanesh A, Gorgin Karaji A. Association between IL-33 gene polymorphism (Rs7044343) and risk of allergic rhinitis. Immunol Investig. 2022;51:29\u201339.","journal-title":"Immunol Investig"},{"key":"438_CR68","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jaci.2013.12.1080","volume":"134","author":"OE Savenije","year":"2014","unstructured":"Savenije OE, John JMM, Granell R, Kerkhof M, Dijk FN, de Jongste JC, Smit HA, Brunekreef B, Postma DS, Van Steen K. Association of IL33\u2013IL-1 receptor\u2013like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol. 2014;134:170\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR69","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/intimm\/dxn037","volume":"20","author":"Y Kondo","year":"2008","unstructured":"Kondo Y, Yoshimoto T, Yasuda K, Futatsugi-Yumikura S, Morimoto M, Hayashi N, Hoshino T, Fujimoto J, Nakanishi K. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol. 2008;20:791\u2013800.","journal-title":"Int Immunol"},{"key":"438_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coi.2016.05.004","volume":"42","author":"C Hardman","year":"2016","unstructured":"Hardman C, Ogg G. Interleukin-33, friend and foe in type-2 immune responses. Curr Opin Immunol. 2016;42:16\u201324.","journal-title":"Curr Opin Immunol"},{"key":"438_CR71","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.4049\/jimmunol.0900328","volume":"183","author":"E Schneider","year":"2009","unstructured":"Schneider E, Petit-Bertron A-F, Bricard R, Levasseur M, Ramadan A, Girard J-P, Herbelin A, Dy M. IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J Immunol. 2009;183:3591\u20137.","journal-title":"J Immunol"},{"key":"438_CR72","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaci.2014.12.1950","volume":"136","author":"B Bleck","year":"2015","unstructured":"Bleck B, Kazeros A, Bakal K, Garcia-Medina L, Adams A, Liu M, Lee RA, Doris BT, Chiu A, Grunig G. Coexpression of type 2 immune targets in sputum-derived epithelial and dendritic cells from asthmatic subjects. J Allergy Clin Immunol. 2015;136:619\u201327. e615.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR73","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1073\/pnas.1003059107","volume":"107","author":"K Oboki","year":"2010","unstructured":"Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, Nambu A, Abe T, Kiyonari H, Matsumoto K. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci. 2010;107:18581\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"438_CR74","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jaci.2009.12.935","volume":"125","author":"D Pr\u00e9fontaine","year":"2010","unstructured":"Pr\u00e9fontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, Hamid Q. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol. 2010;125:752\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR75","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/jid.2011.446","volume":"132","author":"T Savinko","year":"2012","unstructured":"Savinko T, Matikainen S, Saarialho-Kere U, Lehto M, Wang G, Lehtim\u00e4ki S, Karisola P, Reunala T, Wolff H, Lauerma A. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatology. 2012;132:1392\u2013400.","journal-title":"J Invest Dermatology"},{"key":"438_CR76","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrd2660","volume":"7","author":"R Kakkar","year":"2008","unstructured":"Kakkar R, Lee RT. The IL-33\/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discovery. 2008;7:827\u201340.","journal-title":"Nat Rev Drug Discovery"},{"key":"438_CR77","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/all.13749","volume":"74","author":"I Agache","year":"2019","unstructured":"Agache I, Lau S, Akdis CA, Smolinska S, Bonini M, Cavkaytar O, Flood B, Gajdanowicz P, Izuhara K, Kalayci O. EAACI guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Allergy. 2019;74:855\u201373.","journal-title":"Allergy"},{"key":"438_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","volume":"15","author":"JV Fahy","year":"2015","unstructured":"Fahy JV. Type 2 inflammation in asthma\u2014present in most, absent in many. Nat Rev Immunol. 2015;15:57\u201365.","journal-title":"Nat Rev Immunol"},{"key":"438_CR79","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jaci.2010.11.037","volume":"127","author":"J Lotvall","year":"2011","unstructured":"Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, Lemanske RF Jr, Wardlaw AJ, Wenzel SE, Greenberger PA. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127:355\u201360.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR80","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1111\/all.15210","volume":"77","author":"Y Huang","year":"2022","unstructured":"Huang Y, Li X, Zhu L, Huang C, Chen W, Ling Z, Zhu S, Feng X, Yi C, Gu W. Thrombin cleaves IL-33 and modulates IL\u201033\u2010activated allergic lung inflammation. Allergy. 2022;77:2104\u201320.","journal-title":"Allergy"},{"key":"438_CR81","doi-asserted-by":"crossref","unstructured":"Pasha MA, Patel G, Hopp R, Yang Q. (2019) Role of innate lymphoid cells in allergic diseasesAllergy and asthma proceedings OceanSide Publications, p. 138.","DOI":"10.2500\/aap.2019.40.4217"},{"key":"438_CR82","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/1573395510666140304235916","volume":"9","author":"S Lund","year":"2013","unstructured":"Lund S, Walford H, A Doherty H T. Type 2 innate lymphoid cells in allergic disease. Curr Immunol Rev. 2013;9:214\u201321.","journal-title":"Curr Immunol Rev"},{"key":"438_CR83","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/all.13410","volume":"73","author":"V Siroux","year":"2018","unstructured":"Siroux V, Ballardini N, Soler M, Lupinek C, Boudier A, Pin I, Just J, Nadif R, Anto J, Melen E. The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults. Allergy. 2018;73:1447\u201358.","journal-title":"Allergy"},{"key":"438_CR84","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nri2692","volume":"10","author":"FY Liew","year":"2010","unstructured":"Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010;10:103\u201310.","journal-title":"Nat Rev Immunol"},{"key":"438_CR85","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/all.15072","volume":"77","author":"A Schr\u00f6der","year":"2022","unstructured":"Schr\u00f6der A, Lunding LP, Zissler UM, Vock C, Webering S, Ehlers JC, Orinska Z, Chaker A, Schmidt-Weber CB, Lang NJ. IL\u201037 regulates allergic inflammation by counterbalancing pro\u2010inflammatory IL\u20101 and IL\u201033. Allergy. 2022;77:856\u201369.","journal-title":"Allergy"},{"key":"438_CR86","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/ng.323","volume":"41","author":"DF Gudbjartsson","year":"2009","unstructured":"Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, Thorleifsson G, Helgadottir H, Steinthorsdottir V, Stefansson H. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009;41:342\u20137.","journal-title":"Nat Genet"},{"key":"438_CR87","doi-asserted-by":"crossref","unstructured":"Gordon ED, Palandra J, Wesolowska-Andersen A, Ringel L, Rios CL, Lachowicz-Scroggins ME, Sharp LZ, Everman JL, MacLeod HJ, Lee JW. IL1RL1 asthma risk variants regulate airway type 2 inflammation. JCI insight 1. 2016.","DOI":"10.1172\/jci.insight.87871"},{"key":"438_CR88","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.imbio.2015.02.005","volume":"220","author":"L Vocca","year":"2015","unstructured":"Vocca L, Di Sano C, Uasuf CG, Sala A, Riccobono L, Gangemi S, Albano GD, Bonanno A, Gagliardo R, Profita M. IL-33\/ST2 axis controls Th2\/IL-31 and Th17 immune response in allergic airway diseases. Immunobiology. 2015;220:954\u201363.","journal-title":"Immunobiology"},{"key":"438_CR89","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.4049\/jimmunol.1701455","volume":"200","author":"Y Li","year":"2018","unstructured":"Li Y, Wang W, Lv Z, Li Y, Chen Y, Huang K, Corrigan CJ, Ying S. Elevated expression of IL-33 and TSLP in the airways of human asthmatics in vivo: a potential biomarker of severe refractory disease. J Immunol. 2018;200:2253\u201362.","journal-title":"J Immunol"},{"key":"438_CR90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2014.11.037","volume":"136","author":"CA Christianson","year":"2015","unstructured":"Christianson CA, Goplen NP, Zafar I, Irvin C, Good JT Jr, Rollins DR, Gorentla B, Liu W, Gorska MM, Chu H. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol. 2015;136:59\u201368. e14.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR91","doi-asserted-by":"crossref","unstructured":"Gordon ED, Simpson LJ, Rios CL, Ringel L, Lachowicz-Scroggins ME, Peters MC, Wesolowska-Andersen A, Gonzalez JR, MacLeod HJ, Christian LS. (2016) Alternative splicing of interleukin-33 and type 2 inflammation in asthma. Proceedings of the National Academy of Sciences 113: 8765\u20138770.","DOI":"10.1073\/pnas.1601914113"},{"key":"438_CR92","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/labinvest.2008.82","volume":"88","author":"M Suzukawa","year":"2008","unstructured":"Suzukawa M, Koketsu R, Iikura M, Nakae S, Matsumoto K, Nagase H, Saito H, Matsushima K, Ohta K, Yamamoto K. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest. 2008;88:1245\u201353.","journal-title":"Lab Invest"},{"key":"438_CR93","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1172\/JCI124607","volume":"129","author":"W van de Veen","year":"2019","unstructured":"van de Veen W, Akdis M. The use of biologics for immune modulation in allergic disease. J Clin Investig. 2019;129:1452\u201362.","journal-title":"J Clin Investig"},{"key":"438_CR94","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1111\/bcp.14361","volume":"86","author":"I Nnane","year":"2020","unstructured":"Nnane I, Frederick B, Yao Z, Raible D, Shu C, Badorrek P, van den Boer M, Branigan P, Duffy K, Baribaud F. The first-in\u2010human study of CNTO 7160, an anti\u2010interleukin\u201033 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis. Br J Clin Pharmacol. 2020;86:2507\u201318.","journal-title":"Br J Clin Pharmacol"},{"key":"438_CR95","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.2147\/JIR.S320287","volume":"14","author":"AJ Okragly","year":"2021","unstructured":"Okragly AJ, Corwin KB, Elia M, He D, Schroeder O, Zhang Q, Shiyanova T, Bright S, Dicker SB, Chlewicki L. Generation and characterization of torudokimab (LY3375880): a monoclonal antibody that neutralizes interleukin-33. J Inflamm Res. 2021;14:3823.","journal-title":"J Inflamm Res"},{"key":"438_CR96","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/all.13416","volume":"73","author":"J Aug\u00e9","year":"2018","unstructured":"Aug\u00e9 J, Vent J, Agache I, Airaksinen L, Campo Mozo P, Chaker A, Cingi C, Durham S, Fokkens W, Gevaert P. EAACI position paper on the standardization of nasal allergen challenges. Allergy. 2018;73:1597\u2013608.","journal-title":"Allergy"},{"key":"438_CR97","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/all.13307","volume":"73","author":"J Bousquet","year":"2018","unstructured":"Bousquet J, Arnavielhe S, Bedbrook A, Fonseca J, Morais Almeida M, Todo Bom A, Annesi-Maesano I, Caimmi D, Demoly P, Devillier P. The allergic Rhinitis and its impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: the MASK study. Allergy. 2018;73:505\u201310.","journal-title":"Allergy"},{"key":"438_CR98","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1056\/NEJMcp1412282","volume":"372","author":"LM Wheatley","year":"2015","unstructured":"Wheatley LM, Togias A. Allergic rhinitis. N Engl J Med. 2015;372:456\u201363.","journal-title":"N Engl J Med"},{"key":"438_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13223-018-0280-7","volume":"14","author":"P Small","year":"2018","unstructured":"Small P, Keith PK, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol. 2018;14:1\u201311.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"438_CR100","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1111\/j.1365-2222.2008.03114.x","volume":"38","author":"M Sakashita","year":"2008","unstructured":"Sakashita M, Yoshimoto T, Hirota T, Harada M, Okubo K, Osawa Y, Fujieda S, Nakamura Y, Yasuda K, Nakanishi K. Association of serum interleukin-33 level and the interleukin\u201033 genetic variant with Japanese cedar pollinosis. Clin Experimental Allergy. 2008;38:1875\u201381.","journal-title":"Clin Experimental Allergy"},{"key":"438_CR101","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.2104","volume":"12","author":"JM Mj\u00f6sberg","year":"2011","unstructured":"Mj\u00f6sberg JM, Trifari S, Crellin NK, Peters CP, Van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011;12:1055\u201362.","journal-title":"Nat Immunol"},{"key":"438_CR102","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/intimm\/dxv055","volume":"28","author":"S Akasaki","year":"2016","unstructured":"Akasaki S, Matsushita K, Kato Y, Fukuoka A, Iwasaki N, Nakahira M, Fujieda S, Yasuda K, Yoshimoto T. Murine allergic rhinitis and nasal T h2 activation are mediated via TSLP-and IL-33-signaling pathways. Int Immunol. 2016;28:65\u201376.","journal-title":"Int Immunol"},{"key":"438_CR103","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jaci.2012.02.013","volume":"130","author":"Y Haenuki","year":"2012","unstructured":"Haenuki Y, Matsushita K, Futatsugi-Yumikura S, Ishii KJ, Kawagoe T, Imoto Y, Fujieda S, Yasuda M, Hisa Y, Akira S. A critical role of IL-33 in experimental allergic rhinitis. J Allergy Clin Immunol. 2012;130:184\u201394. e111.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR104","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2222.2011.03867.x","volume":"42","author":"R Kamekura","year":"2012","unstructured":"Kamekura R, Kojima T, Takano K, Go M, Sawada N, Himi T. The role of IL-33 and its receptor ST 2 in human nasal epithelium with allergic rhinitis. Clin Experimental Allergy. 2012;42:218\u201328.","journal-title":"Clin Experimental Allergy"},{"key":"438_CR105","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/all.13272","volume":"73","author":"C Rondon","year":"2018","unstructured":"Rondon C, Campo P, Eguiluz-Gracia I, Plaza C, Bogas G, Galindo P, Mayorga C, Torres M. Local allergic rhinitis is an independent rhinitis phenotype: the results of a 10\u2010year follow\u2010up study. Allergy. 2018;73:470\u20138.","journal-title":"Allergy"},{"key":"438_CR106","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1164\/rccm.201212-2227OC","volume":"188","author":"JL Shaw","year":"2013","unstructured":"Shaw JL, Fakhri S, Citardi MJ, Porter PC, Corry DB, Kheradmand F, Liu Y-J, Luong A. IL-33\u2013responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med. 2013;188:432\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"438_CR107","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.jaci.2015.10.019","volume":"137","author":"EP Lam","year":"2016","unstructured":"Lam EP, Kariyawasam HH, Rana BM, Durham SR, McKenzie AN, Powell N, Orban N, Lennartz-Walker M, Hopkins C, Ying S. IL-25\/IL-33\u2013responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa. J Allergy Clin Immunol. 2016;137:1514\u201324.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR108","first-page":"811","volume":"29","author":"Y Du","year":"2015","unstructured":"Du Y, Luo Y, Yang C, Liu J, Wan J, Wang K. Discussion IL-33 and its receptor ST2 associated with the pathogenesis of allergic rhinitis. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi\u2009=\u2009Journal of Clinical Otorhinolaryngology. Head Neck Surg. 2015;29:811\u20134.","journal-title":"Head Neck Surg"},{"key":"438_CR109","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1398-9995.2011.02735.x","volume":"67","author":"Y Kim","year":"2012","unstructured":"Kim Y, Yang T, Park CS, Ahn SH, Son B, Kim J, Lim D, Jang T. Anti-IL\u201033 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy. 2012;67:183\u201390.","journal-title":"Allergy"},{"key":"438_CR110","doi-asserted-by":"crossref","unstructured":"Kitano M, Fukuoka S, Adachi N, Hisamitsu T, Sunagawa M. (2022) Shoseiryuto Ameliorated TDI-Induced Allergic Rhinitis by Suppressing IL-33 Release from Nasal Epithelial Cells. Pharmaceutics 14: 2083.","DOI":"10.3390\/pharmaceutics14102083"},{"key":"438_CR111","first-page":"1","volume":"4","author":"H Renz","year":"2018","unstructured":"Renz H, Allen KJ, Sicherer SH, Sampson HA, Lack G, Beyer K, Oettgen HC. Food allergy. Nat Reviews Disease Primers. 2018;4:1\u201320.","journal-title":"Nat Reviews Disease Primers"},{"key":"438_CR112","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jaci.2012.02.001","volume":"129","author":"AW Burks","year":"2012","unstructured":"Burks AW, Tang M, Sicherer S, Muraro A, Eigenmann PA, Ebisawa M, Fiocchi A, Chiang W, Beyer K, Wood R. ICON: food allergy. J Allergy Clin Immunol. 2012;129:906\u201320.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR113","doi-asserted-by":"publisher","first-page":"e185630","DOI":"10.1001\/jamanetworkopen.2018.5630","volume":"2","author":"RS Gupta","year":"2019","unstructured":"Gupta RS, Warren CM, Smith BM, Jiang J, Blumenstock JA, Davis MM, Schleimer RP, Nadeau KC. Prevalence and severity of food allergies among US adults. JAMA Netw open. 2019;2:e185630\u2013185630.","journal-title":"JAMA Netw open"},{"key":"438_CR114","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.12984","volume":"41","author":"J Turnbull","year":"2015","unstructured":"Turnbull J, Adams H, Gorard DA. The diagnosis and management of food allergy and food intolerances. Aliment Pharmacol Ther. 2015;41:3\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"438_CR115","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5114\/pdia.2013.34162","volume":"30","author":"WA \u017bukiewicz-Sobczak","year":"2013","unstructured":"\u017bukiewicz-Sobczak WA, Wr\u00f3blewska P, Adamczuk P, Kopczy\u0144ski P. Causes, symptoms and prevention of food allergy. Adv Dermatology Allergology\/Post\u0119py Dermatologii i Alergologii. 2013;30:113\u20136.","journal-title":"Adv Dermatology Allergology\/Post\u0119py Dermatologii i Alergologii"},{"key":"438_CR116","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/all.12650","volume":"70","author":"L Castillo-Courtade","year":"2015","unstructured":"Castillo-Courtade L, Han S, Lee S, Mian F, Buck R, Forsythe P. Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model. Allergy. 2015;70:1091\u2013102.","journal-title":"Allergy"},{"key":"438_CR117","doi-asserted-by":"publisher","first-page":"155295","DOI":"10.1016\/j.cyto.2020.155295","volume":"136","author":"J-Q Liu","year":"2020","unstructured":"Liu J-Q, Hu T-Y, Diao K-Y, Yu D, Song Y-N, Mo L-H, Yang G, Liu Z-Q, Liu Z-G, Yang P-C. Cold stress promotes IL-33 expression in intestinal epithelial cells to facilitate food allergy development. Cytokine. 2020;136:155295.","journal-title":"Cytokine"},{"key":"438_CR118","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/intimm\/dxu058","volume":"26","author":"T Muto","year":"2014","unstructured":"Muto T, Fukuoka A, Kabashima K, Ziegler SF, Nakanishi K, Matsushita K, Yoshimoto T. The role of basophils and proallergic cytokines, TSLP and IL-33, in cutaneously sensitized food allergy. Int Immunol. 2014;26:539\u201349.","journal-title":"Int Immunol"},{"key":"438_CR119","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jaci.2016.09.001","volume":"138","author":"J Travers","year":"2016","unstructured":"Travers J, Rochman M, Miracle CE, Cohen JP, Rothenberg ME. Linking impaired skin barrier function to esophageal allergic inflammation via IL-33. J Allergy Clin Immunol. 2016;138:1381\u20133.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR120","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/mi.2017.61","volume":"11","author":"H Han","year":"2018","unstructured":"Han H, Roan F, Johnston LK, Smith DE, Bryce PJ, Ziegler SF. IL-33 promotes gastrointestinal allergy in a TSLP-independent manner. Mucosal Immunol. 2018;11:394\u2013403.","journal-title":"Mucosal Immunol"},{"key":"438_CR121","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2016.02.030","volume":"138","author":"MN Rivas","year":"2016","unstructured":"Rivas MN, Burton OT, Oettgen HC, Chatila T. IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. J Allergy Clin Immunol. 2016;138:801\u201311. e809.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR122","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jaci.2017.02.046","volume":"141","author":"MV Khodoun","year":"2018","unstructured":"Khodoun MV, Tomar S, Tocker JE, Wang YH, Finkelman FD. Prevention of food allergy development and suppression of established food allergy by neutralization of thymic stromal lymphopoietin, IL-25, and IL-33. J Allergy Clin Immunol. 2018;141:171\u20139. e171.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR123","doi-asserted-by":"crossref","unstructured":"Chinthrajah S, Cao S, Liu C, Lyu S-C, Sindher SB, Long A, Sampath V, Petroni D, Londei M, Nadeau KC. Phase 2a randomized, placebo-controlled study of anti\u2013IL-33 in peanut allergy. JCI insight 4. 2019.","DOI":"10.1172\/jci.insight.131347"},{"key":"438_CR124","doi-asserted-by":"publisher","first-page":"606","DOI":"10.20344\/amp.11963","volume":"32","author":"T Torres","year":"2019","unstructured":"Torres T, Ferreira EO, Gon\u00e7alo M, Mendes-Bastos P, Selores M, Filipe P. Update on atopic dermatitis. Acta Med Port. 2019;32:606\u201313.","journal-title":"Acta Med Port"},{"key":"438_CR125","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2340\/00015555-3510","volume":"100","author":"S Bylund","year":"2020","unstructured":"Bylund S, von Kobyletzki LB, Svalstedt M, Svensson \u00c5. Prevalence and incidence of atopic dermatitis: a systematic review. Acta dermato-venereologica. 2020;100:320\u20139.","journal-title":"Acta dermato-venereologica"},{"key":"438_CR126","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/21556660.2019.1619570","volume":"8","author":"E Kowalska-Ol\u0119dzka","year":"2019","unstructured":"Kowalska-Ol\u0119dzka E, Czarnecka M, Baran A. Epidemiology of atopic dermatitis in Europe. J drug Assess. 2019;8:126\u20138.","journal-title":"J drug Assess"},{"key":"438_CR127","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","volume":"139","author":"ZCC Fuxench","year":"2019","unstructured":"Fuxench ZCC, Block JK, Boguniewicz M, Boyle J, Fonacier L, Gelfand JM, Grayson MH, Margolis DJ, Mitchell L, Silverberg JI. Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. J Invest Dermatology. 2019;139:583\u201390.","journal-title":"J Invest Dermatology"},{"key":"438_CR128","unstructured":"Brandt EB, Sivaprasad U. (2011) Th2 cytokines and atopic dermatitis. J Clin & cellular immunology 2 (3)"},{"key":"438_CR129","first-page":"590","volume":"101","author":"W Frazier","year":"2020","unstructured":"Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment. Am Family Phys. 2020;101:590\u20138.","journal-title":"Am Family Phys"},{"key":"438_CR130","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/exd.12076","volume":"22","author":"J Seltmann","year":"2013","unstructured":"Seltmann J, Werfel T, Wittmann M. Evidence for a regulatory loop between IFN-\u03b3 and IL\u201033 in skin inflammation. Exp Dermatol. 2013;22:102\u20137.","journal-title":"Exp Dermatol"},{"key":"438_CR131","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/jid.2012.66","volume":"132","author":"F Cevikbas","year":"2012","unstructured":"Cevikbas F, Steinhoff M. IL-33: a novel danger signal system in atopic dermatitis. J Invest Dermatology. 2012;132:1326\u20139.","journal-title":"J Invest Dermatology"},{"key":"438_CR132","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2019.08.006","volume":"96","author":"Y Imai","year":"2019","unstructured":"Imai Y. Interleukin-33 in atopic dermatitis. J Dermatol Sci. 2019;96:2\u20137.","journal-title":"J Dermatol Sci"},{"key":"438_CR133","first-page":"141","volume":"37","author":"L Kostner","year":"2017","unstructured":"Kostner L, Anzengruber F, Guillod C, Recher M, Schmid-Grendelmeier P, Navarini AA. Allergic contact dermatitis. Immunol Allergy Clin. 2017;37:141\u201352.","journal-title":"Immunol Allergy Clin"},{"key":"438_CR134","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1038\/jid.2012.185","volume":"132","author":"J Meephansan","year":"2012","unstructured":"Meephansan J, Tsuda H, Komine M, Tominaga S-i, Ohtsuki M. Regulation of IL-33 expression by IFN-\u03b3 and tumor necrosis factor-\u03b1 in normal human epidermal keratinocytes. J Invest Dermatology. 2012;132:2593\u2013600.","journal-title":"J Invest Dermatology"},{"key":"438_CR135","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1093\/hmg\/ddi323","volume":"14","author":"M Shimizu","year":"2005","unstructured":"Shimizu M, Matsuda A, Yanagisawa K, Hirota T, Akahoshi M, Inomata N, Ebe K, Tanaka K, Sugiura H, Nakashima K. Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Hum Mol Genet. 2005;14:2919\u201327.","journal-title":"Hum Mol Genet"},{"key":"438_CR136","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s10753-017-0673-7","volume":"41","author":"G Peng","year":"2018","unstructured":"Peng G, Mu Z, Cui L, Liu P, Wang Y, Wu W, Han X. Anti-IL-33 antibody has a therapeutic effect in an atopic dermatitis murine model induced by 2, 4-dinitrochlorobenzene. Inflammation. 2018;41:154\u201363.","journal-title":"Inflammation"},{"key":"438_CR137","first-page":"323","volume":"30","author":"B Bielory","year":"2010","unstructured":"Bielory B, Bielory L. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin. 2010;30:323\u201336.","journal-title":"Immunol Allergy Clin"},{"key":"438_CR138","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1167\/iovs.08-3365","volume":"50","author":"A Matsuda","year":"2009","unstructured":"Matsuda A, Okayama Y, Terai N, Yokoi N, Ebihara N, Tanioka H, Kawasaki S, Inatomi T, Katoh N, Ueda E. The role of interleukin-33 in chronic allergic conjunctivitis. Investig Ophthalmol Vis Sci. 2009;50:4646\u201352.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"438_CR139","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/intimm\/dxq035","volume":"22","author":"S Matsuba-Kitamura","year":"2010","unstructured":"Matsuba-Kitamura S, Yoshimoto T, Yasuda K, Futatsugi-Yumikura S, Taki Y, Muto T, Ikeda T, Mimura O, Nakanishi K. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis. Int Immunol. 2010;22:479\u201389.","journal-title":"Int Immunol"},{"key":"438_CR140","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1167\/iovs.15-16563","volume":"56","author":"Y Asada","year":"2015","unstructured":"Asada Y, Nakae S, Ishida W, Hori K, Sugita J, Sudo K, Fukuda K, Fukushima A, Suto H, Murakami A. Roles of epithelial cell\u2013derived type 2\u2013Initiating cytokines in experimental allergic conjunctivitis. Investig Ophthalmol Vis Sci. 2015;56:5194\u2013202.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"438_CR141","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fimmu.2019.00627","volume":"10","author":"SJ Bracken","year":"2019","unstructured":"Bracken SJ, Abraham S, MacLeod AS. Autoimmune theories of chronic spontaneous urticaria. Front Immunol. 2019;10:627.","journal-title":"Front Immunol"},{"key":"438_CR142","first-page":"1067","volume":"9","author":"M Maurer","year":"2021","unstructured":"Maurer M, Khan DA, Komi DEA, Kaplan AP. Biologics for the use in chronic spontaneous urticaria: when and which. J Allergy Clin Immunology: Pract. 2021;9:1067\u201378.","journal-title":"J Allergy Clin Immunology: Pract"},{"key":"438_CR143","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/all.15603","volume":"78","author":"A Kaplan","year":"2023","unstructured":"Kaplan A, Lebwohl M, Gim\u00e9nez-Arnau AM, Hide M, Armstrong AW, Maurer M. Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances. Allergy. 2023;78:389\u2013401.","journal-title":"Allergy"},{"key":"438_CR144","doi-asserted-by":"crossref","unstructured":"Chaowattanapanit S, Choonhakarn C, Salao K, Winaikosol K, Julanon N, Wongjirattikarn R, Foocharoen C, Sompornrattanaphan M. Increased serum IL-31 levels in chronic spontaneous urticaria and psoriasis with pruritic symptoms. Heliyon 6. 2020.","DOI":"10.1016\/j.heliyon.2020.e05621"},{"key":"438_CR145","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/bjd.13621","volume":"172","author":"A Kay","year":"2015","unstructured":"Kay A, Clark P, Maurer M, Ying S. Elevations in T-helper\u20102\u2010initiating cytokines (interleukin\u201033, interleukin\u201025 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (\u2018idiopathic\u2019) urticaria. Br J Dermatol. 2015;172:1294\u2013302.","journal-title":"Br J Dermatol"},{"key":"438_CR146","doi-asserted-by":"crossref","unstructured":"Trier AM, Ver Heul A, Fredman A, Le V, Wang Z, Auyeung K, Meixiong J, Lovato P, Holtzman MJ, Wang F. IL-33 potentiates histaminergic itch. Journal of Allergy and Clinical Immunology; 2023.","DOI":"10.1016\/j.jaci.2021.12.582"},{"key":"438_CR147","doi-asserted-by":"crossref","unstructured":"Pushparaj PN, Tay HK, H\u2019ng SC, Pitman N, Xu D, McKenzie A, Liew FY, Melendez AJ. (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proceedings of the National Academy of Sciences 106: 9773\u20139778.","DOI":"10.1073\/pnas.0901206106"},{"key":"438_CR148","doi-asserted-by":"publisher","first-page":"615236","DOI":"10.3389\/fimmu.2020.615236","volume":"11","author":"PW West","year":"2021","unstructured":"West PW, Bahri R, Garcia-Rodriguez KM, Sweetland G, Wileman G, Shah R, Montero A, Rapley L, Bulfone-Paus S. Interleukin-33 amplifies human mast cell activities induced by complement anaphylatoxins. Front Immunol. 2021;11:615236.","journal-title":"Front Immunol"},{"key":"438_CR149","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1398-9995.2012.02859.x","volume":"67","author":"M Komai-Koma","year":"2012","unstructured":"Komai-Koma M, Brombacher F, Pushparaj P, Arendse B, McSharry C, Alexander J, Chaudhuri R, Thomson N, McKenzie A, McInnes I. Interleukin\u201033 amplifies I g E synthesis and triggers mast cell degranulation via interleukin\u20104 in na\u00efve mice. Allergy. 2012;67:1118\u201326.","journal-title":"Allergy"},{"key":"438_CR150","doi-asserted-by":"publisher","first-page":"100045","DOI":"10.1016\/j.waojou.2019.100045","volume":"12","author":"MM Antunes","year":"2019","unstructured":"Antunes MM, Coelho BSL, Vichi TM, Dos Santos EA, Gondim FKB, Diniz AB, Aguilar EC, Cara DC, Porto LCJ, de Castro IC. Oral supplementation with capsaicin reduces oxidative stress and IL-33 on a food allergy murine model. World Allergy Organ J. 2019;12:100045.","journal-title":"World Allergy Organ J"},{"key":"438_CR151","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/all.12839","volume":"71","author":"E Kim","year":"2016","unstructured":"Kim E, Kim J, Samivel R, Bae JS, Chung YJ, Chung PS, Lee S, Mo JH. Intralymphatic treatment of flagellin\u2013ovalbumin mixture reduced allergic inflammation in murine model of allergic rhinitis. Allergy. 2016;71:629\u201339.","journal-title":"Allergy"},{"key":"438_CR152","doi-asserted-by":"publisher","first-page":"36150","DOI":"10.1038\/srep36150","volume":"6","author":"J Li","year":"2016","unstructured":"Li J, Zhang L, Chen X, Chen D, Hua X, Bian F, Deng R, Lu F, Li Z, Pflugfelder SC. Pollen\/TLR4 innate immunity signaling initiates IL-33\/ST2\/Th2 pathways in allergic inflammation. Sci Rep. 2016;6:36150.","journal-title":"Sci Rep"},{"key":"438_CR153","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.imlet.2010.04.005","volume":"131","author":"X Zhiguang","year":"2010","unstructured":"Zhiguang X, Wei C, Steven R, Wei D, Wei Z, Rong M, Zhanguo L, Lianfeng Z. Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice. Immunol Lett. 2010;131:159\u201365.","journal-title":"Immunol Lett"},{"key":"438_CR154","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbrc.2009.06.008","volume":"386","author":"X Liu","year":"2009","unstructured":"Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun. 2009;386:181\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"438_CR155","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1164\/rccm.200805-666OC","volume":"179","author":"J Kearley","year":"2009","unstructured":"Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1\/ST2\u2013IL-33 pathway. Am J Respir Crit Care Med. 2009;179:772\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"438_CR156","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1046\/j.1365-2745.2002.01494.x","volume":"32","author":"K Oshikawa","year":"2002","unstructured":"Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Experimental Allergy. 2002;32:1520\u20136.","journal-title":"Clin Experimental Allergy"},{"key":"438_CR157","doi-asserted-by":"crossref","unstructured":"Allinne J, Scott G, Birchard D, Agrawal A, Ben L-H, Lim WK, Kim JH, Kamat V, Murphy A, Sleeman M. IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammationEur respiratory soc. 2018.","DOI":"10.1183\/13993003.congress-2018.OA1944"},{"key":"438_CR158","first-page":"428","volume":"23","author":"K Taniguchi","year":"2013","unstructured":"Taniguchi K, Yamamoto S, Hitomi E, Inada Y, Suyama Y, Sugioka T, Hamasaki Y. Interleukin 33 is induced by tumor necrosis factor alpha and interferon gamma in keratinocytes and contributes to allergic contact dermatitis. J Investig Allergol Clin Immunol. 2013;23:428\u201334.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"438_CR159","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/cea.13027","volume":"47","author":"P Salamon","year":"2017","unstructured":"Salamon P, Shefler I, Moshkovits I, Munitz A, Horwitz Klotzman D, Mekori Y, Hershko A. IL-33 and IgE stimulate mast cell production of IL\u20102 and regulatory T cell expansion in allergic dermatitis. Clin Experimental Allergy. 2017;47:1409\u201316.","journal-title":"Clin Experimental Allergy"},{"key":"438_CR160","doi-asserted-by":"publisher","first-page":"26369","DOI":"10.1074\/jbc.M704916200","volume":"282","author":"H Hayakawa","year":"2007","unstructured":"Hayakawa H, Hayakawa M, Kume A, Tominaga S-i. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 2007;282:26369\u201380.","journal-title":"J Biol Chem"},{"key":"438_CR161","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/all.12861","volume":"71","author":"E Anderson","year":"2016","unstructured":"Anderson E, Kobayashi T, Iijima K, Bartemes K, Chen CC, Kita H. IL-33 mediates reactive eosinophilopoiesis in response to airborne allergen exposure. Allergy. 2016;71:977\u201388.","journal-title":"Allergy"},{"key":"438_CR162","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","volume":"121","author":"WB Cherry","year":"2008","unstructured":"Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol. 2008;121:1484\u201390.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR163","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.4049\/jimmunol.1000730","volume":"185","author":"B Stolarski","year":"2010","unstructured":"Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY. IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol. 2010;185:3472\u201380.","journal-title":"J Immunol"},{"key":"438_CR164","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1399-0039.2008.01185.x","volume":"73","author":"M Ali","year":"2009","unstructured":"Ali M, Zhang G, Thomas W, McLean C, Bizzintino J, Laing I, Martin A, Goldblatt J, Le Sou\u00ebf P, Hayden C. Investigations into the role of ST2 in acute asthma in children. Tissue Antigens. 2009;73:206\u201312.","journal-title":"Tissue Antigens"},{"key":"438_CR165","doi-asserted-by":"publisher","first-page":"e12724","DOI":"10.1111\/sji.12724","volume":"89","author":"E Gasiuniene","year":"2019","unstructured":"Gasiuniene E, Janulaityte I, Zemeckiene Z, Barkauskiene D, Sitkauskiene B. Elevated levels of interleukin-33 are associated with allergic and eosinophilic asthma. Scand J Immunol. 2019;89:e12724.","journal-title":"Scand J Immunol"},{"key":"438_CR166","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/pai.12597","volume":"27","author":"PC Schr\u00f6der","year":"2016","unstructured":"Schr\u00f6der PC, Casaca VI, Illi S, Schieck M, Michel S, B\u00f6ck A, Roduit C, Frei R, Lluis A, Genuneit J. IL-33 polymorphisms are associated with increased risk of hay fever and reduced regulatory T cells in a birth cohort. Pediatr Allergy Immunol. 2016;27:687\u201395.","journal-title":"Pediatr Allergy Immunol"},{"key":"438_CR167","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/iji.12306","volume":"44","author":"GA Queiroz","year":"2017","unstructured":"Queiroz GA, Costa RdS, Alcantara-Neves N, Nunes de Oliveira Costa G, Barreto ML, Carneiro VL, Figueiredo C. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population. Int J Immunogenet. 2017;44:51\u201361.","journal-title":"Int J Immunogenet"},{"key":"438_CR168","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/apa.16176","volume":"111","author":"R Riikonen","year":"2022","unstructured":"Riikonen R, Ter\u00e4sj\u00e4rvi J, Lauhkonen E, Nuolivirta K, He Q, Korppi M. Interleukin 1 receptor-like 1 rs13408661\/13431828 polymorphism is associated with persistent post\u2010bronchiolitis asthma at school age. Acta Paediatr. 2022;111:628\u201335.","journal-title":"Acta Paediatr"},{"key":"438_CR169","doi-asserted-by":"publisher","first-page":"e78099","DOI":"10.1371\/journal.pone.0078099","volume":"8","author":"W Nakanishi","year":"2013","unstructured":"Nakanishi W, Yamaguchi S, Matsuda A, Suzukawa M, Shibui A, Nambu A, Kondo K, Suto H, Saito H, Matsumoto K. IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis. PLoS ONE. 2013;8:e78099.","journal-title":"PLoS ONE"},{"key":"438_CR170","doi-asserted-by":"publisher","first-page":"AB73","DOI":"10.1016\/j.jaci.2016.12.286","volume":"139","author":"M Londei","year":"2017","unstructured":"Londei M, Kenney B, Los G, Marino MH. A phase 1 study of ANB020, an anti-IL-33 monoclonal antibody in healthy volunteers. J Allergy Clin Immunol. 2017;139:AB73.","journal-title":"J Allergy Clin Immunol"},{"key":"438_CR171","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000337764","volume":"158","author":"D Asaka","year":"2012","unstructured":"Asaka D, Yoshikawa M, Nakayama T, Yoshimura T, Moriyama H, Otori N. Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis. Int Arch Allergy Immunol. 2012;158:47\u201350.","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Journal of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-025-00438-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12950-025-00438-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-025-00438-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T18:02:45Z","timestamp":1747072965000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal-inflammation.biomedcentral.com\/articles\/10.1186\/s12950-025-00438-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":171,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["438"],"URL":"https:\/\/doi.org\/10.1186\/s12950-025-00438-w","relation":{},"ISSN":["1476-9255"],"issn-type":[{"value":"1476-9255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}